Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    VEGFR2/KDR/Flk-1 Antibody (522302), mFluor Violet 450 SE, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rat Monoclonal Antibody
Supplier: Novus Biologicals FAB4432MFV450
Description
VEGFR2/KDR/Flk-1 Monoclonal antibody specifically detects VEGFR2/KDR/Flk-1 in Mouse samples. It is validated for Flow Cytometry, Immunocytochemistry, CyTOFSpecifications
| VEGFR2/KDR/Flk-1 | |
| Monoclonal | |
| mFluor Violet 450 SE | |
| 50mM Sodium Borate | |
| Rat | |
| 0.1 mL | |
| Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases | |
| 3791 | |
| Store at 4C in the dark. | 
| Flow Cytometry, Immunocytochemistry, CyTOF | |
| 522302 | |
| Flow Cytometry, Immunocytochemistry, CyTOF-ready | |
| CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2 | |
| Mouse myeloma cell line NS0-derived recombinant mouse VEGFR2/KDR/Flk-1, Ala20-Glu762, Accession # P35918 | |
| RUO | |
| Primary | |
| Mouse | |
| IgG1 | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction